Häftad, Franska, 2010
252 kr
Skickas inom 5-8 vardagar
Germán Velásquez – författare
Visar alla böcker från författaren Germán Velásquez. Handla med fri frakt och snabb leverans.
5 produkter
5 produkter
- Häftad, Franska, 2024
232 kr
Skickas inom 5-8 vardagar
- Häftad, Franska, 2021
328 kr
Skickas inom 5-8 vardagar
- Häftad, Engelska, 2021
343 kr
Skickas inom 10-15 vardagar
This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that wouldenable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered:COVID-19 Vaccines: Between Ethics, Health and EconomicsMedicines and Intellectual Property: 10 Years of the WHO Global StrategyRe-thinking Global and Local Manufacturing of Medical Products After COVID-19Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 ShockIntellectual Property and Access to Medicines and VaccinesThe World Health Organization Reforms in the Time of COVID-19Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19. - Häftad, Engelska, 2025
567 kr
Skickas inom 10-15 vardagar
This book presents reflections and research that highlight tensions in the ongoing negotiations on pandemic preparedness treaties and revisions to the International Health Regulations, underscoring the geopolitical divide between developed and developing countries. It advocates regional health initiatives as a response to the multilateral impasse and reflects on the erosion of foundational public health concepts such as "essential medicines". New pandemics are inevitable. How can we best prepare for them and, above all, how can we avoid the mistakes and injustices made during the COVID-19 pandemic? Negotiations are underway to formulate a binding international treaty on prevention and preparedness to ensure fairer responses to future pandemics. This book is intended as a critical contribution to the current debates.How can equitable access to medicines and diagnostics be guaranteed when they are produced in a small number of countries? How can we explain the fact that current funding for cooperation in the field of health is in the hands of a small group of Northern countries and foundations from the North? How can the role of the World Health Organization be strengthened? WHO now plays only a minor role in coordinating public health policies. How is it that the concept of “essential medicines”, a major advance in public health policy, is being replaced by that of “medical countermeasures”, a term more in line with the private sectors?Preparing for future pandemics forces us to ask ourselves: how can we safeguard the general interest, the defense of human rights and public health?Negotiating Global Health Policies: Tensions and Dilemmas is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO), the World Trade Organization (WTO), and the World Intellectual Property Organization (WIPO) who participate in international negotiations on health and development. Academics and students of medicine, health sciences, law, sociology and political science, as well as intergovernmental organizations and non-governmental organizations who work on access to medicines and global health issues, also would find the book of interest.
